Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(66.7%)
Phase 2
2(33.3%)
6Total
Phase 3(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02121665Phase 3Completed

Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.

Role: lead

NCT02203812Phase 3Completed

Effect of Probiotic Lozenge on Gingivitis and Periodontitis

Role: lead

NCT02174757Phase 3Completed

Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis

Role: lead

NCT01870362Phase 3Completed

Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis

Role: lead

NCT01110447Phase 2Completed

Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation

Role: lead

NCT01008293Phase 2Completed

Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life

Role: lead

All 6 trials loaded